Plasma Vaporization of the Prostate for Treatment of Benign Prostatic Hypertrophy: A review of clinical and cost-effectiveness, and safety
CADTH
Record ID 32014000788
English
Authors' recommendations:
Findings from six RCTs and one retrospective study support BPVP as a reliable alternative to TURP, with better efficacy outcomes and similar complication rates in short and medium term follow-up periods. For follow-up period up to 100 months, limited evidence showed that BPVP reduced BPH symptoms and reoperation rates compared to TURP. There was no evidence found on the cost-effectiveness of BPVP compared to TURP, for patients with BPH.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/pdf/htis/apr-2014/RC0527%20Plasma%20vaporization%20for%20BPH%20-%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Prostatic Hyperplasia
- Laser Therapy
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.